Laparoscopic surgery less bleeding, fast recovery

Due to the progress of surgery, drugs such as target new development, the current treatment for colorectal cancer is quite progress, but also a good opportunity to heal. 

 Such as watching baseball on television at the scene clearly Khussaiby 

 China Medical University Hospital, director of colorectal surgery Chen understanding that the current treatment of colorectal cancer with surgery, the recent use of laparoscopic surgery, not only less bleeding, fast recovery, but also significantly reduce the number of days of hospitalization, many patients three days after surgery can be discharged. 

 He described laparoscopic surgery as in the television watching the Yankees game than at the scene but also clearly visible pitcher Wang Chien-ming's every move, now the use of laparoscopic surgery can be more easily removed lesions. 

 U.S. Food and Drug Administration (FDA) also confirmed that the use of laparoscopic resection of colorectal cancer surgery, the recurrence rate with the traditional surgery, the survival rate of a considerable. 

 Required medical treatment of metastatic colorectal cancer 

 Liver, lung colorectal cancer is the most vulnerable parts of distant metastases, metastatic colorectal cancer to be the use of medication, Chen-liang said that drug treatment is also good, can also greatly enhance the survival rate, the traditional chemotherapy drugs such as 5-FU have oral, injection two options, as well as drug targets, such as angiogenesis inhibitors and epidermal growth factor inhibitors. 

 Target the treatment of colorectal cancer patients to break through the transfer, not surgery, the survival of the plight of drugs can target cancer cells in a special lock structure, the eradication of cancer cells without harming normal cells, unlike traditional chemotherapy to destroy cancer cells at the same time injury to normal tissue. 

 To angiogenesis inhibitors, its surrounding cancer cells can inhibit angiogenesis, so that cancer cells lose their source of nutrients, the international large-scale study of Phase III clinical trial noted that the combined chemotherapy angiogenesis inhibitors, than the efficacy of chemotherapy alone, survival increased. 

 Chen Liang said that the operations or the use of different drug treatment effect, varies from person to person. Generally speaking, the effectiveness of the drug target good, but very expensive drugs, the U.S. Food and Drug Administration has approved Cancer Center angiogenesis inhibitors (Avastin) to target the treatment of first-line drugs. Due to restrictions on domestic health care, it is in the second-line treatment fails, the third-line treatment benefit.